More people than ever are taking GLP-1 receptor agonists—drugs like Ozempic (semaglutide), Wegovy, and Mounjaro. These medications, originally developed for type 2 diabetes, are now widely prescribed for weight loss. They work by mimicking the body’s natural GLP-1 hormone, which regulates blood sugar, slows stomach emptying, suppresses appetite, and alters gut motility. This creates a […]

The post GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin appeared first on Psychedelics Today.

Previous articleTherapy or Threat? UK Expert Warns of Rising Ketamine Addiction as Phase III Alcoholism Trial Launches
Next articlePα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK Moves to Ease Schedule I Research Restrictions